Unique ID issued by UMIN | UMIN000015856 |
---|---|
Receipt number | R000018451 |
Scientific Title | Detection of myocardial ischemia by CT perfusion imaging in comparison with N-13 ammonia PET |
Date of disclosure of the study information | 2014/12/05 |
Last modified on | 2016/03/24 09:53:53 |
Detection of myocardial ischemia by CT perfusion imaging in comparison with N-13 ammonia PET
Myocardial CT perfusion versus N-13 ammonia PET
Detection of myocardial ischemia by CT perfusion imaging in comparison with N-13 ammonia PET
Myocardial CT perfusion versus N-13 ammonia PET
Japan |
coronary artery disease
Cardiology | Radiology |
Others
NO
To determine diagnostic accuracy of CT perfusion imaging for detecting myocardial ischemia in comparison with N-13 ammonia PET imaging
Bio-equivalence
Diagnostic accuracy of combination of CT perfusion and CT coronary angiography for detecting myocardial ischemia
Single arm
Non-randomized
Open -but assessor(s) are blinded
Uncontrolled
1
Diagnosis
Device,equipment |
Cardiac CT and N-13 ammonia PET for patients with coronary artery disease
45 | years-old | <= |
85 | years-old | >= |
Male and Female
Subjects with written informed consent
1. Body weight >75kg
2. Elevated serum creatinine (>1.5 mg/dL) or calculated creatinine clearance of <60 mL/min
3. History of allergic reaction to iodinated contrast media, History of contrast-induced nephropathy
4. Atrial fibrillation or uncontrolled tachyarrhythmia
5. Advanced atrioventricular block (second- or third-degree heart block)
6. Evidence of acute coronary syndrome
7. Known or suspected moderate or severe aortic stenosis
8. Evidence of severe symptomatic heart failure (New York Heart Association class III or IV)
9. Previous coronary artery bypass or other cardiac surgery
10. Coronary artery intervention within the past 6 months
11. Contraindications to vasodilatory stress (systolic blood pressure <90, recent use of dipyridamole- and
dipyridamole-containing medications, recent use of
methylxanthines, such as aminophylline and caffeine)
12. Profound sinus bradycardia (fewer than 40 beats per minute)
13. Known or suspected intolerance or contraindication to beta-blockers (including known allergy to betablockers, history of moderate to severe bronchospastic lung disease, including moderate to severe asthma, severe pulmonary disease with the use of inhaled bronchodilator over the past year)
14. Presence of intracardiac devices, such as intracardiac defibrillator or metallic implants within the imaging field of view
15. History of high radiation exposure (>2 nuclear or multidetector CT studies) in the 1 month before consent
16. The presence of any other history or condition that the investigator judged to be a significant reason for
exclusion
20
1st name | |
Middle name | |
Last name | Chisato Kondo |
Tokyo Women's Medical University
Department of Diagnostic Imaging and Nuclear Medicine
8-1, Kawada-cho, Shinnjyuku-ku, Tokyo
03-3353-8111
kondo.chisato@twmu.ac.jp
1st name | |
Middle name | |
Last name | Chisato Kondo |
Tokyo Women's Medical University
Department of Diagnostic Imaging and Nuclear Medicine
8-1, Kawada-cho, Shinnjyuku-ku, Tokyo
03-3353-8111
kondo.chisato@twmu.ac.jp
Tokyo Women's Medical University
National funding for scientific researches
NO
2014 | Year | 12 | Month | 05 | Day |
Unpublished
Completed
2013 | Year | 06 | Month | 05 | Day |
2014 | Year | 04 | Month | 01 | Day |
2015 | Year | 10 | Month | 31 | Day |
2016 | Year | 02 | Month | 29 | Day |
2016 | Year | 02 | Month | 29 | Day |
2016 | Year | 03 | Month | 31 | Day |
2014 | Year | 12 | Month | 05 | Day |
2016 | Year | 03 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018451